PR Newswire
MINNEAPOLIS, Nov. 11, 2020
MINNEAPOLIS , Nov. 11, 2020 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in seven states and the commonwealth of Puerto Rico , today announced that it will report financial results for its third quarter ended September 30, 2020 on Wednesday, November 25, 2020 before the market opens.
The Company will hold a conference call and webcast to discuss its business and financial results that same day at 8:30 a.m. Eastern Time ( 7:30 a.m. Central Time ). Interested parties may register to attend the conference call via the following link: http://www.directeventreg.com/registration/event/8084816 . Upon registration, each participant will be provided with call details and a registrant ID for Vireo's conference ID number 8084816. A live audio webcast of the call will also be available in the Events & Presentations section of Vireo's website at https://investors.vireohealth.com/events-and-presentations/default.aspx . A webcast replay will be made available for one year on Vireo's website.
About Vireo Health International, Inc.
Vireo Health International, Inc. ("Vireo" or the "Company") is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally-friendly, state-of-the-art greenhouses and distributes its products through its growing network of Green Goods™ retail dispensaries and through hundreds of third-party dispensaries in seven states. Vireo's team of more than 300 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in eight markets. The Company is operational in seven of those eight markets – including the core markets of Arizona , Maryland , Minnesota , New Mexico , New York , Pennsylvania . The Company holds 32 total retail dispensary licenses, of which 13 are currently open for business. For more information about Vireo Health, please visit www.vireohealth.com .
Contact Information
Investor Inquiries
Sam Gibbons
Vice President, Investor Relations
samgibbons@vireohealth.com
(612) 314-8995
Media Inquiries
Albe Zakes
Vice President, Corporate Communications
albezakes@vireohealth.com
(267) 221-4800
SOURCE Vireo Health International, Inc.